Insulin resistance is not associated with myocardial steatosis in women

Diabetologia

Volumn 54, Issue 7, 2011, Pages 1871-1878

  Krssak M ^a   Winhofer, Y ^a   Gobl C ^a   Bischof, M ^a   Reiter, G ^b   Kautzky Willer, A ^a   Luger, A ^a   Krebs, M ^a   Anderwald, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SIEMENS AG ÖSTERREICH   (Austria)

Author keywords

Glucose metabolism; Insulin resistance; Magnetic resonance spectroscopy; Triacylglycerol

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MYOCARDIAL DISEASE; MYOCARDIAL STEATOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STEATOSIS;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MYOCARDIUM;

EID: 79959688924     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2146-0     Document Type: Article

References (42)

1. M Krebs M Roden 2005 Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature Diabetes Obes Metab 7 621 632 16219006 10.1111/j.1463-1326.2004.00439.x 1:CAS:528:DC%2BD2MXht1amt7zI (Pubitemid 41601067)
2. S Jacob J Machann K Rett, et al. 1999 Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects Diabetes 48 1113 1119 10331418 10.2337/diabetes.48.5.1113 1:CAS:528:DyaK1MXjtFSgt78%3D (Pubitemid 29226360)
3. A Kautzky-Willer M Krssak C Winzer, et al. 2003 Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes Diabetes 52 244 251 12540593 10.2337/diabetes.52.2.244 1:CAS:528:DC%2BD3sXhtFagu7o%3D (Pubitemid 36173175)
4. 1H NMR spectroscopy study Diabetologia 42 113 116 10027589 10.1007/s001250051123 1:CAS:528:DyaK1MXls12msg%3D%3D (Pubitemid 29039748)
5. M Krssak M Roden 2004 The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans Rev Endocr Metab Disord 5 127 134 15041788 10.1023/B:REMD.0000021434.98627.dc 1:CAS:528:DC%2BD2cXisVKrt70%3D (Pubitemid 39012110)
6. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents Diabetes 48 1600 1606 10426379 10.2337/diabetes.48.8.1600 1:CAS:528:DyaK1MXkvVKmsrw%3D (Pubitemid 29356869)
7. GL Vega M Chandalia LS Szczepaniak SM Grundy 2007 Metabolic correlates of nonalcoholic fatty liver in women and men Hepatology 46 716 722 17659597 10.1002/hep.21727 1:CAS:528:DC%2BD2sXhtFWhsr3P (Pubitemid 47436117)
8. G de Simone RB Devereux M Chinali, et al. 2009 Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study Nutr Metab Cardiovasc Dis 19 98 104 18674890 10.1016/j.numecd.2008.04.001
9. AR Wende ED Abel 2009 Lipotoxicity in the heart Biochim Biophys Acta 1801 311 319 19818871
10. H Taegtmeyer 2004 Cardiac metabolism as a target for the treatment of heart failure Circulation 110 894 896 15326079 10.1161/01.CIR.0000139340.88769. D5 (Pubitemid 39128613)
11. LJ Rijzewijk RW van der Meer JW Smit, et al. 2008 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus J Am Coll Cardiol 52 1793 1799 19022158 10.1016/j.jacc.2008.07.062
12. 1H magnetic resonance spectroscopic imaging Magn Reson Med 32 175 180 10.1002/mrm.1910320205 1:CAS:528: DyaK2cXmt1Giurs%3D (Pubitemid 24243297)
13. LS Szczepaniak RL Dobbins GJ Metzger, et al. 2003 Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging Magn Reson Med 49 417 423 12594743 10.1002/mrm.10372 1:CAS:528:DC%2BD3sXisVGktLw%3D (Pubitemid 36262808)
14. JS Reingold JM McGavock S Kaka T Tillery RG Victor LS Szczepaniak 2005 Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method Am J Physiol Endocrinol Metab 289 E935 E939 15972271 10.1152/ajpendo.00095.2005 1:CAS:528:DC%2BD2MXht1Cnt77L (Pubitemid 41504396)
15. 1H MR spectroscopy with respiratory navigator gating in volunteers Radiology 245 251 257 17885193 10.1148/radiol.2451061904 (Pubitemid 47417809)
16. J Felblinger B Jung J Slotboom C Boesch R Kreis 1999 Methods and reproducibility of cardiac/respiratory double-triggered (1)H-MR spectroscopy of the human heart Magn Reson Med 42 903 910 10542349 10.1002/(SICI)1522- 2594(199911)42:5<903::AID-MRM10>3.0.CO;2-N 1:STN:280: DC%2BD3c%2FhtFCrsQ%3D%3D (Pubitemid 29521480)
17. RW van der Meer S Hammer JW Smit, et al. 2007 Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects Diabetes 56 2849 2853 17717279 10.2337/db07-0768 (Pubitemid 350223617)
18. P Iozzo R Lautamaki R Borra, et al. 2009 Contribution of glucose tolerance and gender to cardiac adiposity J Clin Endocrinol Metab 94 4472 4482 19820028 10.1210/jc.2009-0436 1:CAS:528:DC%2BD1MXhsVejtb7L
19. 1H-magnetic resonance spectroscopy study Circulation 116 1170 1175 17698735 10.1161/CIRCULATIONAHA.106.645614 (Pubitemid 47360218)
20. G Bajraktari MS Koltai F Ademaj, et al. 2006 Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes Int J Cardiol 110 206 211 16297997 10.1016/j.ijcard.2005.08.033 (Pubitemid 43786377)
21. RS Velagaleti P Gona ML Chuang, et al. 2010 Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study Circ Cardiovasc Imaging 3 257 263 20208015 10.1161/CIRCIMAGING.109.911438
22. AG Bertoni DC Goff Jr RB D'Agostino Jr, et al. 2006 Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes Care 29 588 594 16505511 10.2337/diacare.29.03. 06.dc05-1501 (Pubitemid 44115359)
23. SR Heckbert W Post GD Pearson, et al. 2006 Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis J Am Coll Cardiol 48 2285 2292 17161261 10.1016/j.jacc.2006.03.072 (Pubitemid 44855426)
24. C Anderwald M Anderwald-Stadler M Promintzer, et al. 2007 The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects Diabetes Care 30 2374 2380 17595351 10.2337/dc07-0422 1:CAS:528:DC%2BD2sXhtV2mu7vK (Pubitemid 47359049)
25. M Promintzer M Krebs J Todoric, et al. 2007 Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor J Clin Endocrinol Metab 92 4306 4312 17726077 10.1210/jc.2006-2522 1:CAS:528: DC%2BD2sXhtlartbrP (Pubitemid 350074749)
26. C Anderwald G Pfeiler P Nowotny, et al. 2008 Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring Eur J Clin Investig 38 227 237 10.1111/j.1365-2362.2008.01932.x 1:STN:280: DC%2BD1c7otVCrsw%3D%3D (Pubitemid 351389138)
27. J Barkhausen SG Ruehm M Goyen T Buck G Laub JF Debatin 2001 MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study Radiology 219 264 269 11274568 1:STN:280:DC%2BD3M7oslKntg%3D%3D (Pubitemid 32234085)
28. RH Mohiaddin M Amanuma PJ Kilner DJ Pennell C Manzara DB Longmore 1991 MR phase-shift velocity mapping of mitral and pulmonary venous flow J Comput Assist Tomogr 15 237 243 2002101 10.1097/00004728-199103000-00009 1:STN:280:DyaK3M7mtFOjsw%3D%3D
29. RW van der Meer M Diamant JJ Westenberg, et al. 2007 Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus J Cardiovasc Magn Reson 9 645 651 17578719 10.1080/10976640601093703 (Pubitemid 46956896)
30. 1H NMR relaxation times of skeletal muscle metabolites at 3 T MAGMA 16 155 159 15042412 10.1007/s10334-003-0029-1 1:CAS:528:DC%2BD2cXktFOqtLs%3D (Pubitemid 38657620)
31. JM McGavock RG Victor RH Unger LS Szczepaniak 2006 Adiposity of the heart, revisited Ann Intern Med 144 517 524 16585666 1:CAS:528: DC%2BD28Xkt1KqsLc%3D (Pubitemid 46780675)
32. LS Szczepaniak RG Victor L Orci RH Unger 2007 Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America Circ Res 101 759 767 17932333 10.1161/CIRCRESAHA.107.160457 1:CAS:528: DC%2BD2sXhtFejsL7L (Pubitemid 350287190)
33. LC Heather K Clarke 2011 Metabolism, hypoxia and the diabetic heart J Mol Cell Cardiol 50 598 605 21262230 10.1016/j.yjmcc.2011.01.007 1:CAS:528:DC%2BC3MXjsFWgt7w%3D
34. H Bugger ED Abel 2008 Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome Clin Sci (Lond) 114 195 210 10.1042/CS20070166 1:CAS:528:DC%2BD1cXksVCqsQ%3D%3D (Pubitemid 351293995)
35. K Morino KF Petersen GI Shulman 2006 Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction Diabetes 55 Suppl 2 S9 S15 17130651 10.2337/db06-S002 1:CAS:528: DC%2BD28XhtlSisr7J (Pubitemid 44927027)
36. L Hue H Taegtmeyer 2009 The Randle cycle revisited: a new head for an old hat Am J Physiol Endocrinol Metab 297 E578 E591 19531645 10.1152/ajpendo.00093. 2009 1:CAS:528:DC%2BD1MXht1ykur7K
37. RW van der Meer S Hammer HJ Lamb, et al. 2008 Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men J Clin Endocrinol Metab 93 2702 2708 18430773 10.1210/jc.2007-2524 (Pubitemid 352008539)
38. VB Schrauwen-Hinderling MK Hesselink R Meex, et al. 2010 Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content J Clin Endocrinol Metab 95 1932 1938 20173015 10.1210/jc.2009-2076 1:CAS:528:DC%2BC3cXltFSnsb0%3D
39. I Zib AN Jacob I Lingvay, et al. 2007 Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes J Investig Med 55 230 236 17850734 10.2310/6650.2007.00003 1:CAS:528:DC%2BD2sXht1SmtrvM (Pubitemid 47555941)
40. RW van der Meer LJ Rijzewijk HW de Jong, et al. 2009 Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus Circulation 119 2069 2077 19349323 10.1161/CIRCULATIONAHA.108.803916
41. WB Kannel M Hjortland WP Castelli 1974 Role of diabetes in congestive heart failure: the Framingham Study Am J Cardiol 34 29 34 10.1016/0002-9149(74) 90089-7 1:STN:280:DyaE2c3ltFKrug%3D%3D
42. MJ Legato A Gelzer R Goland, et al. 2006 Gender-specific care of the patient with diabetes: review and recommendations Gend Med 3 131 158 16860272 10.1016/S1550-8579(06)80202-0 (Pubitemid 44069479)